These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26885364)

  • 21. Extended-Spectrum
    Pandit R; Awal B; Shrestha SS; Joshi G; Rijal BP; Parajuli NP
    Interdiscip Perspect Infect Dis; 2020; 2020():6525826. PubMed ID: 32377184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Antibiotic Susceptibility Patterns of Extended-Spectrum ß-Lactamase and Metallo-ß-Lactamase-Producing Uropathogenic Escherichia coli Isolates.
    Ghadiri H; Vaez H; Razavi-Azarkhiavi K; Rezaee R; Haji-Noormohammadi M; Rahimi AA; Vaez V; Kalantar E
    Lab Med; 2014; 45(4):291-6. PubMed ID: 25316659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of extended spectrum beta lactamase in urinary isolates.
    Tankhiwale SS; Jalgaonkar SV; Ahamad S; Hassani U
    Indian J Med Res; 2004 Dec; 120(6):553-6. PubMed ID: 15654142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia.
    Al-Otaibi FE; Bukhari EE
    Saudi Med J; 2013 Feb; 34(2):171-6. PubMed ID: 23396464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended spectrum beta-lactamase producing multidrug resistant urinary isolates from children visiting Kathmandu Model Hospital.
    Dhakal S; Manandhar S; Shrestha B; Dhakal R; Pudasaini M
    Nepal Med Coll J; 2012 Jun; 14(2):136-41. PubMed ID: 23671965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
    Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R
    Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
    Kader AA; Angamuthu K
    Saudi Med J; 2005 Jun; 26(6):956-9. PubMed ID: 15983682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-Vitro Biofilm Formation and Antimicrobial Resistance of
    Raya S; Belbase A; Dhakal L; Govinda Prajapati K; Baidya R; Kishor Bimali N
    Biomed Res Int; 2019; 2019():1474578. PubMed ID: 31641666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of Extended-Spectrum
    Abayneh M; Tesfaw G; Abdissa A
    Can J Infect Dis Med Microbiol; 2018; 2018():4846159. PubMed ID: 30651898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Isolation of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli From Community-Onset Urinary Tract Infection Cases in Uttarakhand, India.
    Kumar N; Chatterjee K; Deka S; Shankar R; Kalita D
    Cureus; 2021 Mar; 13(3):e13837. PubMed ID: 33854854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiological and Clinical Profile of Uropathogenic Escherichia coli Isolates in Kathmandu University Hospital.
    Sherchan JB; Gurung P; Karkee P; Ranabhat N; Shrestha N; Ohara H
    J Nepal Health Res Counc; 2016 Jan; 14(32):33-8. PubMed ID: 27426709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Population structure of drug-susceptible,-resistant and ESBL-producing Escherichia coli from community-acquired urinary tract".
    Hertz FB; Nielsen JB; Schønning K; Littauer P; Knudsen JD; Løbner-Olesen A; Frimodt-Møller N
    BMC Microbiol; 2016 Apr; 16():63. PubMed ID: 27067536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.